XPhyto Therapeutics Corp. (OTCMKTS:XPHYF) Short Interest Down 34.3% in April

XPhyto Therapeutics Corp. (OTCMKTS:XPHYFGet Rating) was the target of a significant decline in short interest during the month of April. As of April 30th, there was short interest totalling 2,300 shares, a decline of 34.3% from the April 15th total of 3,500 shares. Based on an average daily volume of 13,100 shares, the days-to-cover ratio is currently 0.2 days.

OTCMKTS XPHYF opened at $0.63 on Friday. The firm’s fifty day simple moving average is $0.73 and its two-hundred day simple moving average is $0.88. XPhyto Therapeutics has a 12-month low of $0.46 and a 12-month high of $1.99. The firm has a market capitalization of $49.08 million, a P/E ratio of -2.75 and a beta of -1.03.

XPhyto Therapeutics Company Profile (Get Rating)

XPhyto Therapeutics Corp. operates as a bioscience company in Germany and Canada. It develops drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications; and psychedelic medicine to treat mental health-related medical conditions, such as depression, anxiety, addiction, and trauma-related stress disorder.

Featured Articles

Receive News & Ratings for XPhyto Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XPhyto Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.